S-3

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

SEC Filing Details

Document Details

Form
Filing Date
Feb 9, 2021
Document Date
Feb 9, 2021
Form Description
Simplified registration form
Filing Group
Registration Statements
Company
KemPharm
Issuer
KEMPHARM, INC